Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines

Eli Lilly and Co raised the top-end of its 2020 profit forecast on Thursday and reported better-than-expected quarterly results, as customers stocking up medicines such as diabetes drug Trulicity during the coronavirus pandemic boosted sales.